238 Gemcitabine (GEM) as salvage treatment in patients (pts) with advanced colorectal cancer (CRC) progressing after treatment with 5-fluorouracil (FU), irinotecan (lrl) and oxaliplatin (oxa)

Authors :: L. Gallo
C. Caroti
C. Aschele
Mauro D'Amico
Sara Lonardi
S. Garrè
Silvio Monfardini
P. Pronzato
Micaela Stefani
L.M. Pasetto
Source :: European Journal of Cancer Supplements. 1:S74
Publication Year :: 2003
Publisher :: Elsevier BV, 2003.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Salvage treatment
Gemcitabine
Oxaliplatin
Irinotecan
Advanced colorectal cancer
Fluorouracil
Internal medicine
medicine
In patient
business
After treatment
medicine.drug

Tools